StonvexLoading…
StonvexStonvexStonvexCore line items from L's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $858.00M | $3.17B | $2.35B | $1.61B |
Operating Income | $463.00M | $2.28B | $1.74B | $1.05B |
Net Income | $337.00M | $1.67B | $1.26B | $761.00M |
EPS (Diluted) | $1.63 | $7.97 | $6.03 | $3.61 |
Total Assets | $85.65B | $86.35B | $85.94B | $84.67B |
Total Liabilities | $66.06B | $66.71B | $66.72B | $66.28B |
Cash & Equivalents | $843.00M | $495.00M | $567.00M | $447.00M |
Free Cash Flow OCF − CapEx | $-132.00M | $2.70B | $2.27B | $1.51B |
Shares Outstanding | 206.27M | 209.10M | 209.88M | 210.97M |